Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAZE-X1 in hospitalized adults with COVID-19 pneumonia
2021-005247-78Phase 2Completed
- Sponsor
- Tenax Therapeutics
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bazedoxifene in coronavirus disease 2019 (COVID-19) and pneumonia (3 arms), sponsored by Tenax Therapeutics. Primary endpoint: Safety and tolerability. Started Dec 2021; status: completed.
02
Drugs
bazedoxifene
03
Conditions
coronavirus disease 2019 (COVID-19)pneumonia
Beyond the preview
Go deeper on 2021-005247-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005247-78.